A promising future treatment for lupus
By GREGORY ZELLER // There’s a long tunnel ahead, but for millions around the world suffering from lupus, the light at the end shines brightly. That’s the fervent belief of…
Biotech
Before the cure, an HIV inhibitor?
By GREGORY ZELLER A cure for AIDS? Let’s not get ahead of ourselves. Few people understand the molecular world like Stony Brook prof Carol Carter, and the longtime researcher will tell…
Move complete, Codagenix takes aim at Zika
By GREGORY ZELLER // Be afraid, Zika virus. With 1,500 square feet of new wet-lab space and buckets of confidence, the big thinkers at Codagenix are targeting your chemical code…
BioSpecifics surges on international breakout
A high-flying international performance by its flagship product Xiaflex marked a big year for Lynbrook pharma firm BioSpecifics Technologies Corp. The biopharmaceutical company reported its fourth-quarter and full-year 2015 financials…
Chembio misses on drop in Latin American biz
By GREGORY ZELLER // An oversupplied Latin American market put a dent in Chembio Diagnostic’s 2015 earnings, but coming battles with the Zika virus may turn fortunes around. That was…
Chembio lands $550K grant for Zika test
Chembio Diagnostics has been awarded a $550,000 “catalyst grant” to develop a rapid test for the Zika virus and similar maladies. The grant comes from Microsoft co-founder Paul G. Allen,…
Diversification nips Applied DNA numbers
It wasn’t a record quarter, but Applied DNA Sciences maintained momentum and stayed true to its ongoing diversification strategy in the first quarter of Fiscal 2016. That according to James…
Hairpin tops $1M in RNA licensing deals
A Cold Spring Harbor Laboratory spinoff with less than a year under its belt has sped past $1 million in licensing revenue on the lab’s patented “short hairpin RNA” technology….
Codagenix preps for fight against Zika virus
By GREGORY ZELLER // A Stony Brook startup that digitally recreates viruses in order to reprogram their genomes is preparing to take on the Zika virus, which World Health Organization…
The Debrief: Linda Amper is breathing life into the life sciences
The Long Island Association has hired former OSI Pharmaceuticals exec Linda Amper to help launch Long Island Bio, a business-development platform to be co-chaired by Cold Spring Harbor Laboratory chief…
Codagenix making all the right moves
By GREGOERY ZELLER // A seven-figure Regional Economic Development Council award is set to push an innovative influenza vaccine toward human trials. Codagenix, a 2012 startup cofounded by Farmingdale State…
DepYmed wins Accelerate funding
By Gregory Zeller // A Cold Spring Harbor biotech startup is the 10th and final recipient in the first co-funding round backed by Accelerate Long Island and the Long Island…
The Debrief: Getting Broad Hollow out of park
A Long Island lifer – he earned an undergraduate degree at C.W. Post and an MBA at Adelphi University before serving as president of the Lake Success-based subsidiary of Norwegian…
Biohub awards $900K in research funding
Thirteen grants totaling $900,000 have been awarded by the Long Island Bioscience Hub in its first-ever funding round. The hub – a National Institutes of Health-supported partnership between Stony Brook…
NYC exec named to bioentrepreneur program
A business-development expert with a biomedical background has been named the Long Island Bioscience Hub’s latest bioentrepreneur-in-residence. Derek Brand, who most recently served as vice president of business development at…